(2026). MET-mediated phosphorylation of YANK2 at Y282 inhibits NEDD4L-dependent SUMOylation and degradation, promoting chemoresistance in glioblastoma. Molecular Biomedicine.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"MET-mediated Phosphorylation of YANK2 at Y282 Inhibits NEDD4L-dependent SUMOylation and Degradation, Promoting Chemoresistance in Glioblastoma."
Molecular Biomedicine 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"MET-mediated Phosphorylation of YANK2 at Y282 Inhibits NEDD4L-dependent SUMOylation and Degradation, Promoting Chemoresistance in Glioblastoma."
Molecular Biomedicine, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.